Source: International Congress 2018 – Translational models of the immunopathology that underlies airway obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Anatriello (São José dos Campos, Brazil), A. Britto (São Paulo, Brazil), R. Albertini (São José dos Campos, Brazil), A. De Oliveira (São Paulo, Brazil), A. Keller (São José dos Campos, Brazil), F. Aimbire (São José dos Campos, Brazil). Lactobacillus bulgaricus reduces the expression of Toll-like 4 receptor on dendritic cells and attenuates the airway inflammation in asthmatic mice. 1107

Member's Comments

No comment yet.

Related content which might interest you: Attenuated cytokine response and enhanced toll-like receptor expression by budesonide in bronchial epithelial cells Source: Eur Respir J 2006; 28: Suppl. 50, 101s Year: 2006 Toll-like receptors expression in induced sputum cells of asthmatic patients Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Over-expression of SIGIRR attenuates TLR 4,5,9-mediated immune responses in human airway epithelial cells Source: Annual Congress 2009 - Mechanisms of infection: what's new? Year: 2009 Role of Toll-like receptor 4 in acute pulmonary inflammation induced by bacterial components in mice Source: Eur Respir J 2005; 26: Suppl. 49, 730s Year: 2005 The purinergic receptor P2Y2 mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation Source: Annual Congress 2010 - Asthma: basic science and clinical studies Year: 2010 The protective effects of SIGIRR on flagellin-induced acute inflammation of the airway in mice Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host Year: 2008 Altered expression of toll-like receptor (TLR)-2 and TLR-4 on alveolar macrophages (AM) in inflammatory lung disease Source: Eur Respir J 2003; 22: Suppl. 45, 588s Year: 2003 Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology Year: 2008 TLR-4 downregulation in COPD impairs cytokine release from monocytes and Th1-lymphocytes in response to bacterial endotoxin Source: Annual Congress 2009 - What is new in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease? Year: 2009 EP4 agonist increases myeloid derived suppressor cells activity and reduces airway inflammatory events in a murine model of asthma Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms Year: 2020 Soluble biglycan promotes ovalbumin induced airway inflammation by modulating dendritic cell function in mice Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019 Effect of muscarinic receptors inhibition on cytokine release and inflammatory cells infiltration in the airway of cat as an animal model for COPD Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 ILC2 cells from severe allergic and eosinophilic asthma demonstrate increased expression of TSLP receptor (TSLPR) and enhanced proliferative capacity. Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man Year: 2021 RANTES expression induced by Toll-like receptor 3 and 4 ligands on rat airway smooth muscle cells Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 TLR4 mediates LPS-induced mucus hypersecretion in rat airway Source: Annual Congress 2007 - Epithelial networks in the airways Year: 2007 YS4: Regulation of allergic airway disease by IL-4/IL-13 activated macrophages and dendritic cells Source: Lung Science Conference 2011 - Immune system dysregulation in chronic lung disease Year: 2011 IL-33 augments rhinovirus-induced type 2 immune responses in asthma via selective upregulation of one chain of the IL-33 receptor. Source: International Congress 2017 – "Alarming" immunological patterns in asthma Year: 2017 CCL6 produced by eosinophils drives allergic airway inflammation in mice Source: International Congress 2019 – Modelling and monitoring of airway diseases Year: 2019 Protease-activated receptor 1 activation exaggerates allergic airway inflammation in mice Source: Annual Congress 2008 - Understanding allergic airway inflammation with the help of animal models Year: 2008 Effects of the novel toll-like receptor 7 (TLR7) agonist AZD8848 on allergen-induced responses in patients with mild asthma Source: Annual Congress 2012 - New bronchodilators and other novel drugs for asthma and COPD Year: 2012